EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma

Nicky A Beelen, Stefan J J Molenbroeck, Lisette Groeneveld, Christien E Voorter, Gerard M J Bos, Lotte Wieten

Immunogenetics · 2024

DOI: 10.1007/s00251-024-01336-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunogenetics, 2024. Verfasst von Nicky A Beelen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands. Hauptthemen laut MEDLINE: Multiple Myeloma, Receptors, KIR, Killer Cells, Natural, Epitopes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Foundation Limburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of malignant plasma cells in the bone marrow. Myeloma cells are susceptible to killing by natural killer (NK) cells, but NK cells fail to control disease progression, suggesting immunosuppression. The activation threshold of NK-effector function is regulated by interaction between KIRs and self-HLA class I, during a process called “education” to ensure self-tolerance. NK cells can respond to diseased cells based on the absence of HLA class I expression (“Missing-self” hypothesis). The HLA and KIR repertoire is extremely diverse; thus, the present study aimed to characterize potential variances in genotypic composition of HLA Class I NK-epitopes and KIRs between MM patients and healthy controls. Genotypic expression of KIR and HLA (HLA-C group-C1/C2 and Bw4 motifs (including HLA-A*23, A*24, A*32) were analyzed in 172 MM patients and 195 healthy controls. Compared to healthy controls, we did not observe specific KIR genes or genotypes, or HLA NK-epitopes with higher prevalence among MM patients. The presence of all three HLA NK-epitopes (C1 + C2 + Bw4 + ) was not associated with MM occurrence. However, MM patients were more likely to be C1 - /C2 + /Bw4 + ( p = 0.049, OR 1.996). In line with this, there was a trend of increased genetic co-occurrence of Bw4 and KIR3DL1 in MM patients ( p = 0.05, OR 1.557). Furthermore, MM patients were more likely to genetically express both C2/KIR2DL1 and Bw4/KIR3DL1 ( p = 0.019, OR 2.453). Our results reveal an HLA NK-epitope combination that is associated with the occurrence of MM. No specific KIR genotypes were associated with MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaReceptors, KIRKiller Cells, NaturalEpitopesHumansMaleFemaleMiddle AgedAgedGenotypeAdultHistocompatibility Antigens Class I

Stichwörter der Autor:innen

AssociationHuman leukocyte antigen genesKiller-cell immunoglobulin-like receptorMultiple myelomaNatural killer cells

Substanzen

Receptors, KIREpitopesHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.
  • Department of Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands. L.wieten@mumc.nl.
  • Department of Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center+, Maastricht, the Netherlands. L.wieten@mumc.nl.

Förderung

  • Health Foundation Limburg

Zitieren

APA

Beelen, N. A., Molenbroeck, S. J. J., Groeneveld, L., Voorter, C. E., Bos, G. M. J., & Wieten, L. (2024). HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma. Immunogenetics. https://doi.org/10.1007/s00251-024-01336-w

Vancouver

Beelen NA, Molenbroeck SJJ, Groeneveld L, Voorter CE, Bos GMJ, Wieten L. HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma. Immunogenetics. 2024. doi:10.1007/s00251-024-01336-w

BibTeX
@article{Beelen2024,
  author = {Beelen, Nicky A and Molenbroeck, Stefan J J and Groeneveld, Lisette and Voorter, Christien E and Bos, Gerard M J and Wieten, Lotte},
  title = {HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma},
  journal = {Immunogenetics},
  year = {2024},
  doi = {10.1007/s00251-024-01336-w}
}
Kostenlos starten →